Skip to main content
. 2013 Sep 25;27(5):720–726. doi: 10.1093/ajh/hpt177

Figure 1.

Figure 1.

Effects of paricalcitol and enalapril treatment on cardiac hypertrophy in uremic rats. Development of cardiac hypertrophy in the untreated chronic kidney disease (CKD) group (CKD), manifested by increased heart weight (expressed as percent of body weight) compared with sham controls (C), was effectively averted following 8 weeks of treatment with paricalcitol (Pc) or enalapril (E). Data represent mean ± standard error of the mean. * P < 0.05 vs. CKD.